Search Results - C.M. Kelly
- Showing 1 - 3 results of 3
-
1
Investigating a clinically actionable BRAF mutation for monitoring low-grade serous ovarian cancer: A case report by R. Silva, B. Moran, S. Das, N. Mulligan, M. Doughty, A. Treacy, K. Sheahan, C.M. Kelly, A.G. Duffy, A.S. Perry, D.J. Brennan
Published in Case Reports in Women's Health (2022-04-01)Get full text
Article -
2
Medical Terminations of Pregnancy: A Viable Source of Tissue for Cell Replacement Therapy for Neurodegenerative Disorders by C. M. Kelly, S. V. Precious, E. M. Torres, A. W. Harrison, D. Williams, C. Scherf, U. M. Weyrauch, E. L. Lane, N. D. Allen, R. Penketh, N. N. Amso, P. J. Kemp, S. B. Dunnett, A. E. Rosser
Published in Cell Transplantation (2011-05-01)Get full text
Article -
3
Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress by S. Bhatia, D. Davar, S. Thomas, A.W. Silk, R.C. Wu, R. Ladwa, S.J. Park, C.M. Kelly, D.J. Wong, J. Grewal, N. Vohra, A.M. Lim, J. Puegero, C. Verschraegen, B. Zhong, I. Lowy, M. Fury, M. Cristea
Published in EJC Skin Cancer (2024-01-01)Get full text
Article
